Can the metabolic syndrome identify children with insulin resistance?

Pediatric Diabetes

Volumn 8, Issue 5, 2007, Pages 272-277

  Hirschler, Valeria ^a,b   Calcagno, Maria L ^a   Aranda, Claudio ^a   Maccallini, Gstavo ^a   Jadzinsky, Mauricio ^a  

^a HOSPITAL DURAND   (Argentina)

^b NONE   (Argentina)

Author keywords

Children; Insulin resistance; Metabolic syndrome; Waist circumference

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHILD; CHILD HEALTH; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; WAIST CIRCUMFERENCE;

ADIPONECTIN; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INFANT; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X;

EID: 34548707148     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00282.x     Document Type: Article

References (34)

1. Berenson GS, Srinivasan SR, Bao W et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1998: 338: 1650-1656.
2. Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001: 24: 683-689.
3. Haffner SM, Valdez RA, Hazuda HP et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992: 41: 715-722.
4. Tanner JM. Growth at Adolescence: With a General Consideration of the Effects of Hereditary and Environmental Factors upon Growth and Maturation from Birth to Maturity, 2nd edn. Oxford, England: Blackwell Scientific, 1962.
5. Must A, Dallal GE, Dietz WH. Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness. Clin Nutr 1991: 53: 839-884.
6. National High Blood Pressure Education Working Group on High Blood Pressure in Children and Adolescents: The Fourth Report on the Diagnosis, Evaluation and Treatment on High Blood Pressure in Children and Adolescents. Pediatrics 2004: 114: 555-576.
7. Sinha R, Fisch G, Teague B et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002: 346: 802-810 (Erratum, N Engl J Med 2002: 346: 1756).
8. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the ADA Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997: 20: 1183-1197.
9. Young-Hyman D, Schlundt D, Herman L, De Luca F, Counts D. Evaluation of the insulin resistance syndrome in 5 to 10 year old overweight/obese African American children. Diabetes Care 2001: 24: 1359-1364.
10. Matthews DR, Hosker JP, Rudenski AS, NaylorBA, Treacher DF, Turner RC. Homeostasis model assessment; insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985: 28: 412-419.
11. Mc Auley K, Williams S, Mann J et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001: 24: 460-464.
12. Weyer C, Funahashi T, Tanaka S. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001: 86: 1930-1935.
13. Weiss R, Dufour S, Groszmann A. Low adiponectin levels in adolescent obesity: A marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab 2003: 88: 2014-2018.
14. Ridker PM. High-sensitivity C-reactive protein. Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001: 103: 1813-1818.
15. Festa A, D'Agostino R, Howard G. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000: 102: 42-47.
16. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final Report. Bethesda, MD: National Heart, Lung, and Blood Institute, 2002.
17. de Ferranti S, Gauvreau K, Ludwig D et al. Prevalence of the metabolic syndrome in American adolescents findings from the Third National Health and Nutrition Examination Survey. Circulation 2004: 110: 294-297.
18. NGHS C oordinating C enter. NHLBI Growth and Health Study (NGHS) Data Monitoring Report. Baltimore, MD: Maryland Medical Research, 1998.
19. Zhu S, Wang Z, Heshka S et al. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: Clinical action thresholds. Am J Clin Nutr 2002: 76: 743-749.
20. Bao W, Srinivasan SR, Wattigney WA et al. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study. Arch Intern Med 1994: 154: 1842-1847.
21. Chen W, Srinivasan SR, Elkasabany A et al. Cardiovascular risk factors clustering features of insulin resistance syndrome (syndrome X) in a biracial (black-white) population of children, adolescents, and young adults: The Bogalusa Heart Study. Am J Epidemiol 1999: 150: 667-674.
22. Weiss R, Dzuria J, Burget T et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004: 350: 2362-2374.
23. Freedman DS, Serdula MK, S at Srinivasan SR, Berenson GS. Relation of circumferences and skinfold thicknesses to lipid and insulin concentrations in children and adolescents: The Bogalusa Heart Study. Am J Clin Nutr 1999: 69: 308-317.
24. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. Pediatrics 1999: 103: 1175-1182.
25. Hirschler V, Aranda C, Calcagno ML, Maccalini G, Jadzinsky M. Can waist circumference identify children with the metabolic syndrome? Arch Pediatr Adolesc Med 2005: 159: 740-744.
26. Ford ES. C-reactive protein concentration and cardiovascular disease risk factors in children. Findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2003: 108: 1053-1058.
27. Jarvisoalo MJ, Harmoinen A, Hakanen M. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 2002: 22: 1323-1328.
28. Wu DM, Chu NF, Shen MH, Chang JB. Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children. J Clin Epidemiol 2003: 56: 94-100.
29. Yamamoto Y, Hirose H, Saito I et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 2002: 103: 137-142.
30. Yang WS, Lee WJ, F unahashi T et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res 2002: 10: 1104-1110.
31. Asayama K, Hayashibe H, Dobashi K et al. Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res 2003: 11: 1072-1079.
32. Stefan N, Brunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA. Plasma adiponectin concentrations in children: Relationship with obesity and insulinemia. J Clin Endocrinol Metab 2002: 87: 4652-4656.
33. Zietz B, Herfarth H, Paul G et al. Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett 2003: 545: 103-104.
34. American Diabetes Association. The Expert committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003: 26 (Suppl. 1): S5-S20.